ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,591,000 | -26.9% | 216,409 | -20.2% | 0.05% | -23.8% |
| Q2 2022 | $44,572,000 | -24.6% | 271,140 | +2.2% | 0.06% | -7.4% |
| Q1 2022 | $59,077,000 | +36.4% | 265,343 | +45.4% | 0.07% | +28.3% |
| Q4 2021 | $43,310,000 | +3.2% | 182,482 | +1.2% | 0.05% | -8.6% |
| Q3 2021 | $41,958,000 | -30.8% | 180,350 | -38.8% | 0.06% | -29.3% |
| Q2 2021 | $60,647,000 | +1.9% | 294,687 | +1.7% | 0.08% | -6.8% |
| Q1 2021 | $59,519,000 | -51.1% | 289,715 | -49.0% | 0.09% | -8.3% |
| Q4 2020 | $121,786,000 | +150.4% | 567,790 | +113.3% | 0.10% | +7.9% |
| Q3 2020 | $48,645,000 | -11.1% | 266,170 | -10.4% | 0.09% | -19.8% |
| Q2 2020 | $54,733,000 | +12.7% | 296,961 | +23.4% | 0.11% | -5.9% |
| Q1 2020 | $48,546,000 | +71.1% | 240,599 | +58.7% | 0.12% | +110.7% |
| Q4 2019 | $28,372,000 | +36.2% | 151,625 | +16.1% | 0.06% | +24.4% |
| Q3 2019 | $20,837,000 | -36.1% | 130,555 | +0.9% | 0.04% | -36.6% |
| Q2 2019 | $32,604,000 | +13.9% | 129,427 | +8.2% | 0.07% | +7.6% |
| Q1 2019 | $28,625,000 | +14.8% | 119,606 | +10.1% | 0.07% | +1.5% |
| Q4 2018 | $24,939,000 | -18.7% | 108,604 | +0.1% | 0.06% | -4.4% |
| Q3 2018 | $30,664,000 | +25.0% | 108,449 | +29.8% | 0.07% | +17.2% |
| Q2 2018 | $24,532,000 | -38.5% | 83,540 | -47.2% | 0.06% | +16.0% |
| Q1 2018 | $39,916,000 | +133.8% | 158,150 | +100.1% | 0.05% | +22.0% |
| Q4 2017 | $17,070,000 | +24.0% | 79,024 | +6.7% | 0.04% | +13.9% |
| Q3 2017 | $13,766,000 | +16.1% | 74,070 | +7.7% | 0.04% | +16.1% |
| Q2 2017 | $11,859,000 | +11.2% | 68,746 | -1.6% | 0.03% | +6.9% |
| Q1 2017 | $10,667,000 | +15.2% | 69,857 | +11.2% | 0.03% | +11.5% |
| Q4 2016 | $9,258,000 | -37.7% | 62,828 | -46.6% | 0.03% | -39.5% |
| Q3 2016 | $14,861,000 | -15.8% | 117,589 | -24.9% | 0.04% | -15.7% |
| Q2 2016 | $17,659,000 | -28.7% | 156,621 | -34.1% | 0.05% | -32.9% |
| Q1 2016 | $24,754,000 | +11.5% | 237,791 | +20.8% | 0.08% | +15.2% |
| Q4 2015 | $22,207,000 | -14.5% | 196,905 | -17.0% | 0.07% | -17.5% |
| Q3 2015 | $25,987,000 | +6.1% | 237,324 | -7.3% | 0.08% | +6.7% |
| Q2 2015 | $24,487,000 | -2.5% | 255,983 | -5.1% | 0.08% | -1.3% |
| Q1 2015 | $25,113,000 | +15.8% | 269,631 | +1.8% | 0.08% | +18.8% |
| Q4 2014 | $21,690,000 | +40.8% | 264,838 | +10.4% | 0.06% | +39.1% |
| Q3 2014 | $15,400,000 | -22.4% | 239,938 | -26.5% | 0.05% | +58.6% |
| Q2 2014 | $19,842,000 | – | 326,280 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |